CTLA4 and lung cancer: Age, sex ratio, esophageal cancer, head and neck cancer, lung cancer, other cancers, anti‐PD‐L1 monotherapy, anti‐CTLA‐4 monotherapy, and use of steroids before ICIs did not differ substantially between the irAE and non‐irAE groups (Table 1).